iGMDRD112
Canonical SMILES: CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
InChI: InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1
InChI Key: FBOZXECLQNJBKD-ZDUSSCGKSA-N
Drug Class:
Abortifacient AgentsAbortifacient Agents, NonsteroidalAminopterinAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntirheumatic AgentsBCRP/ABCG2 SubstratesBiological FactorsCardiotoxic antineoplastic agentsDermatologicalsEnzyme InhibitorsFolate Analog Metabolic InhibitorFolic Acid AnaloguesFolic Acid AntagonistsHeterocyclic CompoundsHeterocyclic Compounds, 2-RingImmunologic FactorsImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acid Synthesis InhibitorsOAT3 SubstratesOATP1B1/SLCO1B1 SubstratesP-glycoprotein/ABCB1 SubstratesPigments, BiologicalPteridinesPterinsReproductive Control AgentsToxic ActionsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Methotrexate
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |